Results: 1

bosentan a specific and competitive antagonist at endothelin receptor types ETA and ETB, has a slightly higher affinity for ETA receptors than for ETB receptors, indicated for the treatment of pulmonary arterial hypertension

Drugs in the News


Dexamethasone Baloxavir ChloroquinePhosphate Favipiravir Lopinavir Atazanavir Darunavir Nelfinavir Hydroxychloroquine Oseltamivir Remdesivir Umifenovir Azithromycin


DrugCentral Search Overview